Precision therapy management for OSA.
Obstructive Sleep Apnea (OSA) is a sleep disorder characterized by repeated episodes of complete or partial obstruction of the upper airway during sleep, resulting in reduced or completely stopped airflow despite continued breathing efforts. These interruptions typically last 10-30 seconds and can occur 5-30+ times per hour, leading to sleep fragmentation and decreased blood oxygen levels.
OSA affects approximately 1 billion people globally
In the United States, it affects 10-30% of adults
Men are 2-3 times more likely to have OSA than women
Prevalence increases with age, with 30-40% of people over 65 affected
An estimated 80-90% of people with moderate to severe OSA remain undiagnosed
The primary physiological mechanism involves collapse of the upper airway during sleep, specifically in the pharyngeal region.
Ultrasound guided treatment selection
OSA is a diverse condition with multiple underlying causes and sites of obstruction. Treating all patients the same leads to poor compliance and treatment outcomes.
We are developing a wearable ultrasound system to fundamentally change how OSA treatments are managed. By providing a direct visual of obstructions during normal sleep, we hope to eliminate the exhausting trial and error process often used to select and titrate treatments.
We believe that having the right information early in the diagnostic process will save patients and clinicians time, money, and endless frustration.
Contact Us
Interested in learning more? Feel free to contact us and we’ll get back to you as soon as we can!